Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
label applications through the customer's Value Analysis Committee (VAC) for its Recell System. The company now expects total revenues for 2023 in the band of $49.5-$50.5 million, with lower and upper bounds indicating year-over-year growth rates of approximately 45% and 48%, respectively. Previously, the company had guided the total revenues for 2023 in the $51-$53 million range. Shares of RCEL declined 18.9% on Tuesday, in response to the news. Year to date, shares of the company have surged 54.1% against the industry's 12.6% decline. Image Source: Zacks Investment Research Avita's Recell System is a device that allows doctors to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. In June 2023, the FDA expanded the label of RCEL's Recell System to treat patients with full-thickness skin defects based on positive results from the company's pivotal study for soft tissue repair and reconstruction
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- Avita Medical (NASDAQ:RCEL) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare ConferenceGlobeNewswire
- Avita Medical (NASDAQ:RCEL) was upgraded by analysts at BTIG Research from a "sell" rating to a "neutral" rating.MarketBeat
- AVITA Medical to Host Investor Webinar Briefing [Yahoo! Finance]Yahoo! Finance
RCEL
Earnings
- 11/6/25 - Miss
RCEL
Sec Filings
- 11/6/25 - Form 10-Q
- 11/6/25 - Form 8-K
- 10/17/25 - Form SCHEDULE
- RCEL's page on the SEC website